Dysautonomia / autonomic dysfunction

Start here: the body's autopilot

The autonomic nervous system is the autopilot that keeps your internal settings steady while your attention is elsewhere. Stand up and it tightens blood vessels and nudges your heart rate so blood still reaches your brain. Eat and it sends blood to the gut. You never issue these orders; the system handles them in the background.

In long COVID the autopilot loses its calibration. The corrections come too hard, too late, or in the wrong direction. Because one control system touches so many organs, a single underlying problem can produce a scattered list of symptoms that looks, to an outside eye, like several unrelated complaints.

Why the heart races on standing

A large part of the orthostatic story is plumbing, not nerves alone. Many people with autonomic dysfunction and POTS run on a low circulating blood volume. Stand up and gravity pulls blood into the legs and abdomen. With less volume to start, even less returns to the heart, so the only way to keep output up is to raise the heart rate.¹²

This is why a racing heart on standing is a sign of a struggling circulation rather than a weak or anxious one. It also points to why simple measures like extra salt, fluids, and compression help some people: they refill the tank the system is trying to pump from.

moderatelow blood volume well-documentedplumbing, not nerves alone

The preload-failure angle

Invasive exercise testing has uncovered a specific pattern in many patients: preload failure. The heart muscle is fine and squeezes normally, but too little blood comes back to fill it when upright and working, so the amount delivered to the body falls. The left ventricle is normal; the problem is upstream, in what reaches it.

This drives the exercise intolerance and reduced oxygen use that so many people describe, and it links to small fiber neuropathy, found in a subset, where damaged small nerve fibers fail to tighten the veins that should push blood back to the heart.

moderatewell-founded via iCPETsubset show small fiber neuropathy

The autoantibody angle, and why it is contested

A popular hypothesis is that the immune system makes autoantibodies that bind receptors controlling heart rate and blood vessels and switch them on, mimicking adrenaline. Early studies reported such functional autoantibodies in POTS, which fit the picture neatly.³

The neat picture has not held up cleanly. When a later study used standardized assays, the autoantibody levels did not separate patients from healthy controls, and similar antibodies turn up in people with no symptoms at all.⁴ The autoantibody idea remains live and worth testing, but it is contested, not established, and this is exactly the kind of claim to treat with care.

contestedstandardized testing did not separatealso found in healthy people

One misfiring system, many symptoms

Dysautonomia is the hub that ties long COVID symptoms together. The same loss of autonomic control that races the heart also drives ventilatory inefficiency, where breathing runs harder than the body needs, producing breathlessness even when the lungs and scans look normal.

It also produces surges that feel like anxiety, a pounding chest and a sense of alarm, generated by sympathetic overactivity rather than by a worried mind. Naming the autonomic source matters, because it moves the conversation away from blaming the patient and toward a system that can be measured and, in part, managed.

moderatewell-founded for dyspnea and anxiety-like symptomsoverlaps mast cell activation

What helps, and what the evidence says

There is no cure and no single approved treatment, but several measures have support. The non-drug foundation, more salt and fluid, compression, and gradual recumbent conditioning kept below the post-exertional malaise threshold, addresses the low-volume problem directly. Reviews of drug options for POTS describe modest, selective benefits for agents that slow the heart or support blood pressure.⁵

The evidence is thinner than the confidence with which treatments are sometimes offered. A Cochrane review found little reliable trial evidence for commonly used drugs such as fludrocortisone in orthostatic intolerance.⁶ That argues for trying the low-risk basics first and treating any single drug as an experiment to monitor, not a guaranteed fix.

thin trial evidencemodest, selective drug benefitlow-risk basics first

What this means for you

If your heart races when you stand, you feel lightheaded, or you are breathless with a normal chest scan, dysautonomia is a single explanation that can account for all of it at once. The most useful early step is to make it visible, because routine tests often miss it. A standing test that records heart rate and blood pressure lying down and then standing, or a home log of the same, can show the pattern a resting ECG will not.

The low-risk basics, extra salt and fluids, compression, and conditioning kept under your crash threshold, are reasonable to start while you seek a clinician familiar with autonomic problems. If a drug is offered, it is fair to ask what the trial evidence behind it actually shows, since for several common choices it is weaker than the confidence suggests. None of this is a cure, but naming the system at fault is the step that turns a scattered, dismissible set of complaints into something you can measure and manage.

References

Each reference links to the source on PubMed, PMC, or the publisher.

1. Reduced blood volume contributes to orthostatic tachycardia. American Journal of the Medical Sciences, 2007.
2. Blood volume is low in postural tachycardia syndrome. Clinical Autonomic Research, 2024.
3. Functional autoantibodies to adrenergic receptors are reported in postural tachycardia syndrome. Journal of the American Heart Association, 2019.
4. Standardized testing did not separate POTS patients from controls on adrenergic autoantibodies. Circulation, 2022.
5. A review of drug treatments for postural tachycardia syndrome. Journal of Cardiovascular Pharmacology, 2023.
6. Cochrane review finds little reliable evidence for drugs in orthostatic intolerance, including fludrocortisone. Cochrane Database of Systematic Reviews, 2021.